CN103272276B - Anal fistula suppository and preparation method thereof - Google Patents
Anal fistula suppository and preparation method thereof Download PDFInfo
- Publication number
- CN103272276B CN103272276B CN201310203597.5A CN201310203597A CN103272276B CN 103272276 B CN103272276 B CN 103272276B CN 201310203597 A CN201310203597 A CN 201310203597A CN 103272276 B CN103272276 B CN 103272276B
- Authority
- CN
- China
- Prior art keywords
- biological
- anal fistula
- preparation
- suppository
- described step
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention provides an anal fistula biological suppository and a preparation method thereof. The anal fistula biological suppository uses small intestine submucosa tissues of inbred line animals without cell and DNA (deoxyribonucleic acid) components as the raw material, completely reserves the extracellular matrix component and structure, and has a micropore structure. The preparation method of the anal fistula biological suppository comprises the following operation steps: determination of animal source, pretreatment and rough cleaning of small intestine tissues, virus inactivation, cell removal, DNA removal treatment, formation, packaging and sterilization. The anal fistula biological suppository prepared by the method uses an inbred line animal as an animal source, and thus, the hereditary features are pure, stable and uniform, thereby radically ensuring the stability and uniformity of different batches of products; and the anal fistula biological suppository has fewer animal source DNA residues, completely reserves the three-dimensional structure of natural ECM, and has the advantages of low immune source property and high infection resistance.
Description
Technical field
The present invention relates to animal derived Implantable Medical Device technical field, be specifically related to a kind of anal fistula biological suppository and preparation method thereof.
Background technology
Anal fistula is a kind of chronic infective pipeline that anal skin is identical with rectum/anal canal, and be the inevitable outcome after perianal abscess healing, be a kind of common anus benign disease, incidence rate is only second to hemorrhoid and occupies the second of optimum anal and intestinal disease.The main method for the treatment of anal fistula is surgical operation therapy.Traditional modus operandi comprises anal fistulectomy, ligating method for treating anal fistula, fistula road is spacious puts the modus operandi such as drainage, per anum TRANSANAL RECTAL ADVANCEMENT FLAP, all there is the problem of anal function obstacle and recurrence in these operative treatment modes, the incidence rate of postoperative anal incontinence is between 10% ~ 65%, postoperative anal fistula relapse rate is between 10% ~ 20%, and the quality of life of patient is very poor.Think at present, anal fistula healing and anal function protection all should as the key indexs for the treatment of success or failure.The biologic treatment of Wicresoft has become the main development direction of Treatment of Anal Fistula.Biological fibrin glue filling is the biologic treatment means occurred the earliest, but its success rate only has about 20%.2005, de-cell trees-Osima jacoti, Osima excavata (the small intestinal submucosa of CookBiotech Incorporated, SIS) substrate material product is used successfully to Treatment of Anal Fistula, this operation has Wicresoft, patients ' life quality is high, relapse rate is low, success rate reaches 60%, without advantages such as anus dysfunctions, be the huge innovation of anal fistula operative treatment.
Based on the main development direction of to take animal tissue as extracellular matrix (extracellular matrix, the ECM) material of raw material the be medical embedded material of tissue engineering principle.ECM is as compositions such as collagen, non-collagen sugar albumen, aminoglycan, Dan Baiduotang proteoglycan PG, elastin laminins by multiple macromolecular substances, the organic three-dimension integrally of the complexity built up with structure by a certain percentage, for the existence of various cell and activity provide suitable place and microenvironment, the growth of various cell, shape, metabolism, migration, propagation and differentiation can be regulated, and then organization of regulation control and organ dysfunction.A serious consequence of tissue defect is the forfeiture of " soil "-ECM, and this is also the reason that body self cannot realize tissue repair and regeneration.Natural ECM can, as " soil " of tissue regeneration, be desirable tissue renovation material.The cell component removing animal tissue can remove most immunogenicity, and retains ECM composition, can develop desirable hernia patching material.Comprise the ECM materials such as allogeneic dermis, trees-Osima jacoti, Osima excavata, pig dermis, embryo cattle corium for clinical bioactive materials at present.Wherein de-cell submucous layer of small intestine host material is the optimal tissue renovation material that academic circles at present is generally acknowledged.The anal fistula bolt (trade name: Biodesign Surgisis) of U.S. Cook Biotech Incorporated has entered American-European countries market, and achieves good clinical effectiveness.
Biodesign Surgisis product has natural distinctive ECM structure and composition, can initiatively inducing tissue regeneration, and immunogenicity is low, and histocompatibility is good, the advantages such as degradable.But along with the increase of clinical practice, the problem of Biodesign Surgisis product also displays.Clinical studies show: the complication such as Biodesign Surgisis anal fistula bolt product has occurred that serosity in various degree swells in the application, infects, comes off, chronic inflammatory reaction, organization healing are bad, wherein the serosity incidence rate that swells is the highest.Complication may cause disease palindromia, even needs second operation to remove.In addition, the stability of the anti-infection ability of product and the product of different batches and uniformity poor.
On the one hand, animal source DNA remains is the major defect of Biodesign Surgisis product.The production technology of Biodesign Surgisis is not considered and is removed the residual link of DNA, and its product standard does not specify that DNA remains the content (reference standard: YZB/USA 0944-2010) of control yet.Study verified, serosity swell by Th2 inflammatory cytokine react cause, and this reaction be exactly by animal source DNA Chronic immune react caused.On the other hand, Biodesign Surgisis product adopts standard hybridization system pig as animal sources, and hybridization is unstability and the heterogeneity that the individual variation of animal genetic background result in different batches product.Again on the one hand, the vacuum pressing lyophilizing moulding process that Biodesign Surgisis product adopts makes the space structure of SIS host material compress, and destroys natural ECM three dimensional structure, affects the anti-infection ability of product and promotes tissue regeneration ability.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of anal fistula biological suppository, this anal fistula biological suppository is using inbred line animal as animal origin, inherited characteristic is pure, stable, unified, fundamentally ensure that stability and the uniformity of different batches product, animal source DNA remains less and the complete three dimensional structure remaining natural ECM, immunogenicity is low, and anti-infection ability is strong.
A kind of anal fistula biological suppository, it adopts the intestinal submucosa tissue of inbred line animal to be raw material, removes cell component and DNA composition, complete reservation extracellular matrix components and structure, and has microcellular structure.
Described inbred line animal is preferably inbred pig, more preferably Chinese wuzhishan miniature pig inbred-line.
After described removal cell component and DNA composition, DNA residual quantity is 105 ~ 130pg/g.
The aperture of described microcellular structure is 150 ~ 250um, and porosity is 85 ~ 90%.
Described anal fistula biological suppository is rolled into taper shape by 2 ~ 4 layers of monolayer material axle or is pressed into bar shaped by 8 ~ 12 layers of monolayer material, and has penetrability aperture, and the aperture of described penetrability aperture is 0.5 ~ 2mm, and span is 0.5 ~ 1cm.
Described penetrability aperture is for forming by the punching of laser micropore technology.
Another technical problem to be solved by this invention is to provide the preparation method of above-mentioned anal fistula biological suppository, this preparation method is improved and is optimized preparation technology, add DNA and remove link, mechanical oscillation is effectively combined with supersonic oscillations, Freeze Drying Technique and laser micropore technology effective are combined, thus effectively remove animal source DNA, complete structure and the composition remaining natural ECM, make anal fistula biological suppository of the present invention compared with existing similar products, DNA residual quantity is low, and immunogenicity is low, anti-infection ability is high.
The preparation method of above-mentioned anal fistula biological suppository, comprises following operating procedure:
(1) zoogenously to determine and the pre-process of small intestine and previous cleaning
Select inbred line animal as animal origin, the determination of animal varieties adopts the method for patent ZL200510008994.2 defined, gets small intestine's cleaning of fresh slaughtered animals, isolates submucous layer of small intestine, uses water for injection to rinse 3 times.
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, wherein the volumn concentration of peracetic acid is 0.05 ~ 0.2% (being preferably 0.1%), inactivation time is 1 ~ 2h (being preferably 1h), temperature range is 4 ~ 40 DEG C, then clean 2 ~ 5 times in phosphate buffer, each 15min, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.
(3) de-cell
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, first material is inserted in rinse bath, then hydrogen injecting sodium hydroxide solution in rinse bath, open washer, scavenging period is 5 ~ 30min (being preferably 20min), concentration of sodium hydroxide solution is that 5 ~ 100mmol/L (is preferably 5 ~ 20mmol/L, more preferably 10mmol/L), then washer is closed, sodium hydroxide solution is inclined to, inject phosphate buffer to clean, open washer, scavenging period is 5 ~ 20min (being preferably 15min), phosphate buffer repeated washing 2 ~ 5 times, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.
(4) DNA removes process
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, sodium chloride solution is injected rinse bath, open washer, scavenging period is 5 ~ 30min (being preferably 20min), concentration of sodium chloride solution is 0.015mol/l or 2mol/L (being preferably 0.015mol/L), pH value is no more than 7.8, then with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.
(5) molding
This step comprises fixture and fixes, lyophilization and laser micropore punch 3 steps, material 2 ~ 4 layers of axle are rolled into taper shape (as shown in Figure 1) or 8 ~ 12 laminations make bar shaped (as shown in Figure 2), be fixed on fixture (being preferably rustless steel fixture), then water for injection cleaning is used, the material being fixed on fixture is put in freezer dryer, lyophilization is carried out: pre-freeze is to-25 ~-50 DEG C (being preferably-25 DEG C) according to the lyophilizing flow process designed in advance, be incubated 0.5 ~ 4 hour (being preferably 2h), heat up 15 DEG C, be incubated 4 ~ 12 hours (being preferably 8h), heat up 15 DEG C, be incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 25 DEG C, be incubated 4 hours, after lyophilizing completes, use laser micropore puncher punching (i.e. penetrability aperture), pore diameter range is 0.5 ~ 2mm, span is 0.5 ~ 1cm.Described laser micropore punching refers to and utilizes laser technology that material is got micron-sized aperture, uses the punching of laser micropore puncher to be to make material surface form hole, being beneficial to tissue repair.
(6) packaging sterilizing
Pack under aseptic conditions, one deck adopts special strong defensive QI paper, another layer to adopt vinyon, has packed rear employing oxirane and has carried out sterilizing.
In described step (1), inbred line animal is preferably inbred pig, more preferably Chinese wuzhishan miniature pig inbred-line.Described Chinese wuzhishan miniature pig inbred-line refers to the animal varieties that ZL02149030.9 provides, and utilizes brood male female Wuzhi Mountain pig for being ancestral, adopts " son joins mother ", " full ", the inbred pig population cultivated.
As preferably, in described step (2), (3), (4), rinse bath frequency of oscillation is 100 ~ 300rpm, more preferably 200rpm.
As preferably, in described step (2), (3), (4), ultrasonic frequency is 20 ~ 80KHZ, more preferably 45KHZ.
The compound method of phosphate buffer described in the present invention is for claiming 7.9g NaCl, 0.2g KCl, 0.24g KH
2pO
4, 1.8g K
2hPO
4, be dissolved in 800ml distilled water, regulate the pH value to 7.4 of solution with HCl, then adding distil water is settled to 1L.
In the present invention, the use standard of water for injection specifies according in state-promulgated pharmacopoeia.
The ultrasonic washing unit that rinse bath described in the present invention can vibrate is combined with mechanical oscillator by the rinse bath of conventional ultrasonic wave cleaning machine, enable rinse bath that machinery concussion occur while ultrasonic waves for cleaning, achieve mechanical oscillation and combine with ultrasonic waves for cleaning simultaneously and play a role.
Compared with prior art, the present invention has following remarkable advantage and beneficial effect:
The present invention selects inbred line animal as animal origin, after being further preferably Chinese wuzhishan miniature pig inbred-line, make the coefficient of inbreeding of this kind up to 0.991, gene high homogenous, there is the advantage that inherited characteristic is pure, stable, unified, fundamentally ensure that stability and the uniformity of different batches product, making the genetic background difference between individuality very little, thus determine immunogenic gene and the mankind have very high homology.The uniformity of the submucous layer of small intestine ECM material product developed for animal origin with this kind, stability and low immunogenicity are higher than the product be pig with hybridization being raw material.
Preparation method of the present invention is improved and is optimized preparation technology, adds DNA and removes link, determine the standard that product dna is residual.Inactivation of virus of the present invention adopts low concentration peracetic acid-alcoholic solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, de-cell adopts low-concentration sodium hydroxide solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, DNA removes and adopts sodium chloride solution in conjunction with mechanical oscillation and ultrasonic waves for cleaning, all adopts phosphate buffer and water for injection cleaning after every step completes.Inactivation of virus in preparation method, the de-step such as cell and DNA removing is all simultaneously in conjunction with mechanical oscillation and ultrasonic waves for cleaning, mechanical oscillation is effectively combined with supersonic oscillations by preparation method, improve inactivation of virus, de-cell and DNA remove the efficiency of technique, DNA residual quantity significantly reduces, greatly reduce technique consuming time, simplify technological process, whole preparation process only uses peracetic acid-ethanol, sodium hydroxide and sodium chloride three kinds of solution, and concentration is all well below existing technology of preparing, the material of preparation is made to completely eliminated immunogenicity, the complete effective ingredient such as structure and somatomedin remaining natural ECM, remain without poisonous and harmful substance, biocompatibility is good, avirulence, without teratogenecity, without immunoreation after implanting, further, Freeze Drying Technique and laser micropore technology effective are combined innovatively in moulding process, retain natural ECM three dimensional structure, hole does not compress, and the anti-infection ability of product is high.
Accompanying drawing explanation
Shown in Fig. 1 is the structural representation of the conical anal fistula biological suppository of the present invention;
Shown in Fig. 2 is the structural representation of bar shaped anal fistula biological suppository of the present invention;
Shown in Fig. 3 is that schematic diagram cut out by sample in the embodiment of the present invention 2;
Shown in Fig. 4 is optical microscope figure in the embodiment of the present invention 2;
Shown in Fig. 5 is Electronic Speculum ultrastructure figure in the embodiment of the present invention 2.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further described in detail, but is not limited to this.
The preparation of embodiment 1:4 layer anal fistula biological suppository
Preparation method is as follows:
(1) zoogenously to determine and the pre-process of small intestine and previous cleaning
Select Chinese wuzhishan miniature pig inbred-line as animal origin, the determination of animal varieties adopts the method for patent ZL200510008994.2 defined, get small intestine's cleaning of fresh Chinese wuzhishan miniature pig inbred-line of butchering, isolate submucous layer of small intestine, use water for injection to rinse 3 times.
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, wherein the volumn concentration of peracetic acid is 0.05 ~ 0.2% (being preferably 0.1%), inactivation time is 1 ~ 2h (being preferably 1h), temperature range is 4 ~ 40 DEG C, then clean 2 ~ 5 times in phosphate buffer, each 15min, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.Rinse bath frequency of oscillation is 100 ~ 300rpm (being preferably 200rpm), and ultrasonic frequency is 20 ~ 80KHZ (being preferably 45KHZ).
(3) de-cell
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, first material is inserted in rinse bath, then hydrogen injecting sodium hydroxide solution in rinse bath, open washer, scavenging period is 5 ~ 30min (being preferably 20min), concentration of sodium hydroxide solution is that 5 ~ 100mmol/L (is preferably 5 ~ 20mmol/L, more preferably 10mmol/L), then washer is closed, sodium hydroxide solution is inclined to, inject phosphate buffer to clean, open washer, scavenging period is 5 ~ 20min (being preferably 15min), phosphate buffer repeated washing 2 ~ 5 times, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.Rinse bath frequency of oscillation is 100 ~ 300rpm (being preferably 200rpm), and ultrasonic frequency is 20 ~ 80KHZ (being preferably 45KHZ).
(4) DNA removes process
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, sodium chloride solution is injected rinse bath, open washer, scavenging period is 5 ~ 30min (being preferably 20min), concentration of sodium chloride solution is 0.015mol/l or 2mol/L (being preferably 0.015mol/L), pH value is no more than 7.8, then with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop.Rinse bath frequency of oscillation is 100 ~ 300rpm (being preferably 200rpm), and ultrasonic frequency is 20 ~ 80KHZ (being preferably 45KHZ).
(5) molding
This step comprises fixture and fixes, lyophilization and laser micropore punch 3 steps, material 4 layers of axle are rolled into taper shape, be fixed on rustless steel fixture, then water for injection cleaning is used, the material being fixed on fixture is put in freezer dryer, lyophilization is carried out: pre-freeze is to-25 ~-50 DEG C (being preferably-25 DEG C) according to the lyophilizing flow process designed in advance, be incubated 0.5 ~ 4 hour (being preferably 2h), heat up 15 DEG C, be incubated 4 ~ 12 hours (being preferably 8h), heat up 15 DEG C, be incubated 0.5 ~ 4 hour (being preferably 2h), be warming up to 25 DEG C, be incubated 4 hours, after lyophilizing completes, use the punching of laser micropore puncher, pore diameter range is 0.5 ~ 2mm, span is 0.5 ~ 1cm.Described laser micropore punching refers to and utilizes laser technology that material is got micron-sized aperture, uses the punching of laser micropore puncher to be to make material surface form hole, being beneficial to tissue repair.
(6) packaging sterilizing
Pack under aseptic conditions, one deck adopts special strong defensive QI paper, another layer to adopt vinyon, has packed rear employing oxirane and has carried out sterilizing.
Embodiment 2: the physicochemical property of the material prepared by embodiment 1, histology, somatomedin and biology performance detect
1. porosity measurement
Porosity measurement: adopt mercury injection method to measure the porosity of material, and with and contrast with Biodesign Surgisis product.Result: the porosity of the sample that embodiment 1 provides is 87.8 ± 2.51, Biodesign Surgisis product porosity is 78.3 ± 6.38.
2. chemical property detects, and test item comprises virus, acid-base value, endotoxin and DNA residual quantity.
1) test liquid preparation: prepared by test liquid: the thickness uniform parts of sample thief, is cut into 1cm
2fragment, dry after washing, then add in glass container, by total surface area (cm inside and outside sample
2) being 5:1 with the ratio of water (mL), ratio adds water, add a cover and be placed in pressure steam sterilizer, at 121 DEG C ± 1 DEG C heating 30min, by sample and fluid separation applications after heating terminates, be chilled to room temperature as test liquid.Get consubstantiality hydrops and be placed in glass container, with legal system for blank liquid.
2) Viral diagnosis: method: selection Pseudorabies virus is indicator virus, adopts real-time quantitative PCR method to detect viral DNA copies number, detects 3 batch samples.Result: viral DNA copies number 0.
3) acid-base value detects: by the method test of regulation in 5.4.1 in GB/T14233.1 (" medical infusion, blood transfusion, instrument used for injection method of inspection part 1: chemical analysis method "), result: the difference of the pH value of test liquid and blank liquid is no more than 1.5.
4) endotoxin: by 6cm
2sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 DEG C, 72 ± 2hr prepares experimental liquid, lixiviate medium: normal saline.The method specified by GB/T 14233.2-2005 (" medical infusion, blood transfusion, instrument used for injection method of inspection part 2: BiologicalAssays Procedures ") is carried out, and detects 3 batch samples.Result: endotoxin content is less than 5EU/g.
5) DNA residues detection: according to biological preparation residual DNA detection method (" Chinese Pharmacopoeia " 2010, annex IX-B Residual exogenous DNA quantitative determination method), adopt fluorescent staining method to detect the DNA residual quantity of the sample that embodiment 1 provides, and contrast with Biodesign Surgisis product.Result: the DNA residual quantity of the sample that embodiment 1 provides is the DNA residual quantity of 120 ± 15pg/g, Biodesign Surgisis product is 250 ± 45pg/g.
3. histology
1) observation by light microscope: method: the capable hematoxylin-eosin stains of the material after paraffin peplos, inverted phase contrast microscope is observed.Result: acellular and cell debris remains, collagen is micro-continuous in fracture, as shown in Figure 4.
2) Ultrastructural observation.Result: material porous structure, fiber is without fracture, and uniform pore diameter, mean pore size is 200um, and porosity is greater than 85%, as shown in Figure 5.
4. somatomedin detects:
By 6cm
2sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 DEG C, 72 ± 2hr prepares experimental liquid, lixiviate medium: normal saline.ELLISA method is adopted to detect lixiviating solution neutral and alkali somatomedin (bFGF) and VEGF (VEGF) content.Result: bFGF content is 121.8 ± 2.683ng/L, VEGF content is 93.8 ± 3.033ng/L.
5. biology performance detects, and test item comprises cytotoxicity, delayed hypersensitivity, intradermoreaction.
1) cytotoxicity: method: by 6cm
2sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 DEG C, 24 ± 2hr prepares experimental liquid, lixiviate medium: containing the MEM culture medium of serum.Get experimental liquid to test according to the test method specified in GB/T16886.5-2003 (" BiologicalEvaluationofMedicalDevice Part X: stimulate and test with delayed hypersensitivity ").Result: cell-cytotoxic reaction is less than or equal to 1 grade.
2) delayed hypersensitivity: method: by 6cm
2sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 DEG C, 72 ± 2hr prepares experimental liquid, and lixiviate medium is normal saline and Oleum Gossypii semen.Specify to test according to CB/T 16886.10-2005 (" BiologicalEvaluationofMedicalDevice the 10th part: stimulate and test with delayed hypersensitivity ") test method.Result: without delayed hypersensitivity.
3) intradermoreaction: by 6cm
2sample adds the ratio of 1ml lixiviate medium, and 37 ± 1 DEG C, 72 ± 2hr prepares experimental liquid, and lixiviate medium is normal saline and Oleum Gossypii semen.Specify to test according to CB/T 16886.10-2005 (" BiologicalEvaluationofMedicalDevice the 10th part: stimulate and test with delayed hypersensitivity ") test method.Result: the difference of test specimen and solvent control mean score is less than 1.0.
The above embodiment of the present invention can not be used for limiting the present invention to explanation of the present invention, and any change in the implication suitable with claims of the present invention and scope, all should think to be included in the scope of claims.
Claims (15)
1. a preparation method for anal fistula biological suppository, is characterized in that comprising following operating procedure:
(1) zoogenously to determine and the pre-process of small intestine and previous cleaning
Select Chinese wuzhishan miniature pig inbred-line as animal origin, the determination of animal varieties adopts the method for patent ZL200510008994.2 defined, get small intestine's cleaning of fresh slaughtered animals, isolate submucous layer of small intestine, use water for injection to rinse 3 times;
(2) inactivation of virus
Adopt peracetic acid-alcoholic solution method inactivation of viruses, carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, wherein the volumn concentration of peracetic acid is 0.05 ~ 0.2%, inactivation time is 1 ~ 2h, temperature range is 4 ~ 40 DEG C, then clean 2 ~ 5 times in phosphate buffer, each 15min, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop;
(3) de-cell
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, first material is inserted in rinse bath, then hydrogen injecting sodium hydroxide solution in rinse bath, open washer, scavenging period is 5 ~ 30min, concentration of sodium hydroxide solution is 5 ~ 100mmol/L, then washer is closed, sodium hydroxide solution is inclined to, inject phosphate buffer to clean, open washer, scavenging period is 5 ~ 20min, phosphate buffer repeated washing 2 ~ 5 times, detect the pH value of the phosphate buffer after cleaning, after pH reaches 6.5-7.5, with the water for injection cleaning material of flowing, detect when electrical conductivity reaches 1.5 μm/below s and stop,
(4) DNA removes process
Carry out in the constant-temperature ultrasonic washer that this step can be vibrated at rinse bath, sodium chloride solution is injected rinse bath, open washer, scavenging period is 5 ~ 30min, concentration of sodium chloride solution is 0.015mol/l or 2mol/L, pH value is no more than 7.8, then with the water for injection cleaning material of flowing, detects when electrical conductivity reaches 1.5 μm/below s and stop;
(5) molding
This step comprises fixture and fixes, lyophilization and laser micropore punch 3 steps, material 2 ~ 4 layers of axle are rolled into taper shape or 8 ~ 12 laminations make bar shaped, be fixed on fixture, then water for injection cleaning is used, the material being fixed on fixture is put in freezer dryer, lyophilization is carried out: pre-freeze is to-25 ~-50 DEG C according to the lyophilizing flow process designed in advance, be incubated 0.5 ~ 4 hour, heat up 15 DEG C, be incubated 4 ~ 12 hours, heat up 15 DEG C, be incubated 0.5 ~ 4 hour, be warming up to 25 DEG C, be incubated 4 hours, after lyophilizing completes, use the punching of laser micropore puncher, pore diameter range is 0.5 ~ 2mm, span is 0.5 ~ 1cm,
(6) packaging sterilizing
Pack under aseptic conditions, one deck adopts special strong defensive QI paper, another layer to adopt vinyon, has packed rear employing oxirane and has carried out sterilizing.
2. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (2), the volumn concentration of peracetic acid is 0.1%.
3. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (2), inactivation time is 1h.
4. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: be 20min with sodium hydroxide solution to the scavenging period that material cleans in described step (3).
5. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (3), concentration of sodium hydroxide solution is 5 ~ 20mmol/L.
6. the preparation method of a kind of anal fistula biological suppository according to claim 5, is characterized in that: in described step (3), concentration of sodium hydroxide solution is 10mmol/L.
7. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: be 15min with phosphate buffer to the scavenging period that material cleans in described step (3).
8. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (4), sodium chloride solution scavenging period is 20min.
9. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (4), concentration of sodium chloride solution is 0.015mol/L.
10. the preparation method of a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (2), (3), (4), rinse bath frequency of oscillation is 100 ~ 300rpm.
The preparation method of 11. a kind of anal fistula biological suppository according to claim 10, is characterized in that: in described step (2), (3), (4), rinse bath frequency of oscillation is 200rpm.
The preparation method of 12. a kind of anal fistula biological suppository according to claim 1, is characterized in that: in described step (2), (3), (4), ultrasonic frequency is 20 ~ 80KHZ.
The preparation method of 13. a kind of anal fistula biological suppository according to claim 12, is characterized in that: in described step (2), (3), (4), ultrasonic frequency is 45KHZ.
The preparation method of 14. a kind of anal fistula biological suppository according to claim 1, is characterized in that: the fixture in described step (5) is rustless steel fixture.
The preparation method of 15. a kind of anal fistula biological suppository according to claim 1, is characterized in that: the lyophilizing flow process designed in advance in described step (5) is: pre-freeze, to-25 DEG C, is incubated 2h, heat up 15 DEG C, insulation 8h, heats up 15 DEG C, insulation 2h, is warming up to 25 DEG C, is incubated 4 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310203597.5A CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310203597.5A CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103272276A CN103272276A (en) | 2013-09-04 |
| CN103272276B true CN103272276B (en) | 2015-04-22 |
Family
ID=49054963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310203597.5A Active CN103272276B (en) | 2013-05-28 | 2013-05-28 | Anal fistula suppository and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103272276B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106419988B (en) * | 2015-08-11 | 2019-04-12 | 陕西瑞盛生物科技有限公司 | A kind of fistula bolt rolling device and method for coiling for preventing from rolling adhesion |
| CN106419989B (en) * | 2015-08-11 | 2019-04-16 | 陕西瑞盛生物科技有限公司 | A kind of rolling device and method for coiling of biomaterial |
| CN107019642A (en) * | 2017-03-31 | 2017-08-08 | 华东理工大学 | A kind of sustained-release administration type embolism and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101185774A (en) * | 2007-10-25 | 2008-05-28 | 王振军 | Preparation of medical bioavailability bracket material and uses thereof |
| CN101217987A (en) * | 2005-04-29 | 2008-07-09 | 库克生物科技公司 | Fistula graft with deformable sheet-form material |
| US20090054927A1 (en) * | 2007-08-23 | 2009-02-26 | Agnew Charles W | Fistula plugs and apparatuses and methods for fistula plug delivery |
| CN102389323A (en) * | 2005-04-29 | 2012-03-28 | 库克生物科技公司 | Volumetric grafts for treatment of fistulae and related methods and systems |
-
2013
- 2013-05-28 CN CN201310203597.5A patent/CN103272276B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101217987A (en) * | 2005-04-29 | 2008-07-09 | 库克生物科技公司 | Fistula graft with deformable sheet-form material |
| CN102389323A (en) * | 2005-04-29 | 2012-03-28 | 库克生物科技公司 | Volumetric grafts for treatment of fistulae and related methods and systems |
| US20090054927A1 (en) * | 2007-08-23 | 2009-02-26 | Agnew Charles W | Fistula plugs and apparatuses and methods for fistula plug delivery |
| CN101185774A (en) * | 2007-10-25 | 2008-05-28 | 王振军 | Preparation of medical bioavailability bracket material and uses thereof |
Non-Patent Citations (1)
| Title |
|---|
| 脱细胞羊膜与小肠黏膜下层促进大鼠皮肤缺损修复和血管形成;霍艳丽;《中国优秀硕士学位论文全文数据库》;20091115(第11期);第10页的1段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103272276A (en) | 2013-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272278B (en) | Method for preparing animal derived implantable medical biomaterial | |
| CN103272274B (en) | Biological repair tablet for herniae and preparation method thereof | |
| CN107007886B (en) | A kind of biological tissue's host material, preparation method and its usage | |
| EP2968419B1 (en) | Molded placental tissue compositions and methods of making and using the same | |
| CN103301508B (en) | Preparation method of medical cartilage support material | |
| CN102215883A (en) | Compressible/expandable medical graft products, and methods for applying hemostasis | |
| US11529437B2 (en) | Biological tissue matrix material, preparation method therefor and use thereof in otological repair material | |
| CN107224617A (en) | A kind of hydrogel using spleen cell epimatrix as raw material and preparation method thereof | |
| CN111603610B (en) | A kind of preparation method of adipose tissue extracellular matrix | |
| CN103272276B (en) | Anal fistula suppository and preparation method thereof | |
| CN103961752B (en) | Tissue regeneration guiding film and preparation method thereof | |
| CN103301507B (en) | Artificial biological tendon and preparation method thereof | |
| CN103272275B (en) | Biological repair tablet for endocranium and preparation method thereof | |
| CN111084900A (en) | Preparation method and application of acellular fish skin matrix | |
| CN107007882A (en) | A kind of nerve repair material, preparation method and application | |
| CN108079363A (en) | A kind of kit and its application that cell processing is taken off for animal tissue | |
| CN111035807B (en) | A kind of preparation method of ultra-thin APCS graft | |
| CN107050515B (en) | Corneal stroma, preparation method and application | |
| CN108030914A (en) | A kind of Matrigel raw material and preparation method and application | |
| CN105013010B (en) | A kind of laminin film of auxiliary iPS RPE transplanting | |
| CN110507855B (en) | Preparation method of heterogenous costal cartilage for local support effect | |
| León-Mancilla et al. | Three-dimensional collagen matrix scaffold implantation as a liver regeneration strategy | |
| CN106860861B (en) | Immunity enhancing composition, preparation method and application thereof | |
| CN106556706B (en) | Function and application of the disintegrating element for poisonous metalloproteinase 23 in myocardial hypertrophy | |
| WO2021090617A1 (en) | Hydrogel membrane dried product or vitrigel membrane dried product, apparatus and method for manufacturing same, and tympanic membrane treatment device and injury part treatment device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |